Serum IL-17A in Behcet's disease

---

Emiroglu N., Cengiz F. P., ERDEM G. B.

POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.32, sa.5, ss.358-361, 2015 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 32 Sayı: 5
• Basım Tarihi: 2015
• Doi Numarası: 10.5114/pdia.2015.54745
• Dergi Adı: POSTEPY DERMATOLOGII I ALERGOLOGII
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.358-361
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Bezmiâlem Vakıf Üniversitesi Adresli: Hayır

Özet

Introduction: Behcet's disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet's disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.